Newport Daily News
This story is being provided for free as part of a series on childcare during the COVID pandemic, powered by the Solutions Journalism Network and dedicated to delivering solution-oriented stories about problems our community is facing.
A pandemic within a pandemic. That’s what experts are calling it.
Subjected to screens in a year of mostly remote learning, children’s mental health has suffered.
Physically distanced from many of the supports and connections that define childhood and school in a year of unprecedented stressors, “the kids are not OK,” as Vermont Gov. Phill Scott said in February.
Health officials are warning of the significant, negative impacts that online life has had on youth mental health, but AI-based trainings and online therapy could ensure that health services are reachable wherever the child is.
Can Tech Help Solve Mental Health Crisis for Young People? govtech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from govtech.com Daily Mail and Mail on Sunday newspapers.
Joe Biden marks 50M vaccine doses in 37 days; South Korea, Hong Kong administer first vaccinations; 508K US deaths: Latest COVID-19 updates Jorge L. Ortiz, John Bacon and Elinor Aspegren, USA TODAY
The FDA says Johnson & Johnson s COVID vaccine is safe for public use
Replay Video UP NEXT
As he highlighted his administration’s progress in the massive vaccination campaign against the coronavirus Thursday, President Joe Biden made a plea for Americans not to let their guard down despite a dwindling number of infections and hospitalizations in recent weeks.
“This is not a time to relax,’’ Biden said as he warned about the possible impact of virus variants. “We must keep washing our hands, stay socially distanced, and for God’s sake – for God’s sake – wear a mask.’’
USA TODAY
An advisory committee voted unanimously Friday to recommend authorizing a COVID-19 vaccine from Johnson & Johnson for use in adults, paving the way for an expected Food and Drug Administration authorization within the next few days.
Johnson & Johnson agreed to provide 100 million doses of its single-shot vaccine in the U.S. by June, including 20 million by the end of March. Those doses will add to the 300 million doses Pfizer-BioNTech and Moderna each have promised to deliver by the end of July.
The vaccine was shown to be 72% effective in a U.S. trial in which all ethnic, racial and age groups benefited about the same, and was shown to be 85% effective in preventing the most severe disease.